CodeBreak 100 & Prevalence of KRASG12C Mutations Utilizing ctCDA

KRAS G12C Mutations

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

KEYNOTE-177 & Pembrolizumab Monotherapy in MSI-H Pts

MSI-H Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

NTRK-FP Solid Tumors - Integrated Analysis & Larotrectinib in Pts with TRK Fusion

NTRK Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

BLU-667 in RET Fusion+ Solid Tumors

RET Fusion+ Solid Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

DESTINY-CRC01

Her-2 Positive Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

Q+A and Case Presentation

Featuring:
Dr. David Hogan and Dr. Adrian Sacher

NTRK: A Transformative New Paradigm in Oncology

Featuring:
Dr. David Hogan

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel,Q&A

Featuring:
Dr. Parneet Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Patient Monitoring/Patient Tools

Featuring:
Massey Nematollahi

Immune Related Complications From Immune Checkpoint Inhibitors - Dermatologic

Featuring:
Dr. Tom Salopek

Immune Related Complications From Immune Checkpoint Inhibitors - Hepatitis

Featuring:
Dr. Morven Cunningham

Immune Related Complications From Immune Checkpoint Inhibitors - Neurologic

Featuring:
Dr. Dubravka Dodig

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel, Q&A

Featuring:
Dr. Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Rhematologic

Featuring:
Dr. Raman Joshi

Immune Related Complications From Immune Checkpoint Inhibitors - Nephritis

Featuring:
Dr. Gabrielle Cote

Immune Related Complications From Immune Checkpoint Inhibitors - Pneumonitis

Featuring:
Dr. Shane Shapera

Immune Related Complications From Immune Checkpoint Inhibitors - Diarrhea/Colitis

Featuring:
Dr. Nazira Chatur

Clinical Evidence For Immune-therapies In Practice - Cases Discussion Panel, Q&A

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - Breast Cancers

Featuring:
Dr. Dave Cescon

Clinical Evidence For Immune-therapies In Practice - Melanoma

Featuring:
Dr. Scott Ernst

Clinical Evidence For Immune-therapies In Practice - Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - GI Cancers

Featuring:
Dr. Suneil Khanna

Clinical Evidence For Immune-therapies In Practice - GU Cancers

Featuring:
Dr. Nazanin Fallah-Rad

Principles of Immunotherapeutic Strategies

Featuring:
Dr. Linh Nguyen

Therapeutic drug monitoring of oral anticancer drugs

Featuring:
Dr. Steffie Groenland
Dr. Neeltje Steeghs

Durvalumab activity in previously treated patients

Featuring:
Dr. Siddharth Sheth

MAGE-A4 Trial

Featuring:
Dr. Brian Van Tine

FIGHT-202 Study

Featuring:
Dr. Arndt Vogel

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

Sarcoma

Featuring:
Dr. Christine Simmons

Novel Immune Therapy Approaches: From Immune Checkpoint Inhibitors to Adoptive T-Cell Transfer

Featuring:
Dr. Michael Smylie

Canadian Achievements in Cancer Research

Featuring:
Dr. Mark Clemons

Canadian Achievements in Cancer Research

Featuring:
Dr. Lisa Barbera

Evidence For NTRK Inhibitors

Featuring:
Dr. David Hong & Dr. Adrian Sacher

Supportive Care

Featuring:
Dr. Elie Kassouf

New Technologies in Cancer Care

Featuring:
Dr. John Kildea

Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

Broad Indications for Immunotherapy

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

End of Life Quality at Minority-Serving Cancer Centers

Featuring:
Dr. Garrett Wasp

Monteluksat and Rupatadine and their combination with Rituximab

Featuring:
Dr. Rouslan Kotchetkov

Routine ESAS use on OS

Featuring:
Dr. Lisa Barbera

What is the Role of 'Big Data' in Cancer Care

Featuring:
Cindy Perettie, CEO, Foundation Medicine Inc.

Panel Discussion

Future of Precision Medicine

Featuring:
Dr. Trevor Pugh

The Impact of Artificial Intelligence and 'Big Data' on Health Policy

Featuring:
Dr. Catherine Stinson

BioInformatics and the Role of Artificial Intelligence in Cancer Care

Featuring:
Dr. Benjamin Haibe-Kains

How is Technology Impacting Drug Development in Oncology

Featuring:
Dr. Leigh Revers

Lunch Presentation - Biosimilars in Oncology

Featuring:
Dr. Anil Abraham Joy
Dr. Sandeep Sehdev

Special Session: Best of Real World Evidence in Oncology

Featuring:
Dr. Winson Cheung

Best of Oncology East 2018

November 30th, 2018
Toronto, ON

Satellite Symposium - Lunch Presentation - Chemotherapy-Induced Nausea and Vomiting — A Case-Based Presentation

Featuring: Dr. Kasia Jerzak
Shikha Lawrence

Biomarkers to Guide Treatment Decision: PDL-1 and Beyond

Featuring:
Dr. Ming Tsao

CAR T-Cell Therapy: Are we driving in the fast lane?

Featuring:
Dr. Christine Chen

Innovating Clinical Trial Designs to accelerate Immune-Therapies in Cancer 

Featuring:
Dr. Martin Smoragiewicz

Combination Strategies to Enhance Efficacy 

Featuring:
Dr. Adrian Sacher

Panel Discussion 

Featuring:
Dr. Martin Smoragiewicz
Dr. Christine Chen
Dr. Adrian Sacher

The Future of IO Therapies Beyond Checkpoint Inhibitors

Featuring:
Dr. Rosalyn Juergens

Panel Discussion 

Featuring:
Dr. Natasha Leighl
Dr. Henry Conter
Dr. Sunil Verma

The Canadian Advantage – Role of Real World Evidence and Opportunities to Enhance Value of IO Therapies in Canada 

Featuring:
Dr. Natasha Leighl

Case Studies and Panel Discussion 

Featuring:
Dr. Andrew Robinson
Dr. Nancy Nixon
Dr. David Hogg
Dr. Teresa Petrella

Role of Multi-Disciplinary Team in Management of Patients on IO Therapies

Featuring:
Dr. David Hogg

Keynote Lecture: Personalizing Immune-Therapies and Understanding resistance 

Featuring:
Dr. David Carbone

Canadian Immuno-Oncology Summit 2018

November 1st, 2018
Toronto, ON

Initial of BMS-986158 in Phase 1 dose escalation

Featuring:
Dr. John Hilton

PHOENIX Study

Featuring:
Dr. Ali Alkan

AMC303

Featuring:
Dr. Emiliano Calvo

Probiotics in Chemo-induced Diarrhea

Featuring:
Dr. Atul Sharma

NETSARC Study

Featuring:
Dr. Jean-Yves Blay

Panel Discussion 

Featuring:
Dr. David Carbone
Dr. Rosalyn Juergens
Dr. Teresa Petrella
Dr. Ming Tsao
Dr. Sunil Verma

Cost of integrating Immuno-Oncology Therapy in Clinical Practice: Are we prepared?

Featuring:
Dr. Henry Conter

Special Session: Precision Oncology

Featuring:
Dr. Gwyn Bebb

Lunch Symposium - New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw and Roland Coppens

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw & Mark Pasetka

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Nathaniel Bouganim and Veronique Savard

Best of ASCO Montreal 2018 - Supportive Care

Featuring:
Dr. Elie Kassouf

Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

PIVOT Trial

Featuring:
Dr. Adi Diab

Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

MATCH Study

Featuring:
Dr. Young Kwang Chae

Duplicate of Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

Duplicate of HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

Duplicate of PIVOT Trial

Featuring:
Dr. Adi Diab

Duplicate of Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

Duplicate of MATCH Study

Featuring:
Dr. Young Kwang Chae

Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Duplicate of Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Panel Discussion on Biosimilars

Featuring:
Dr. Scott Berry
Flay Charbonneau
Alexandra Chambers
Dr. Andrea Eisen
Dr. Hal Hirte
Dr. Sunil Verma
Dr. Sandy Sehdev
Barry Stein

From Bench to Bedside with Bevacizumab Biosimilars

Featuring:
Dr. Scott Berry

Biosimilars in Breast Cancer: Clinical Implications

Featuring:
Dr. Sunil Verma

Update from CADTH on Biosimilars

Featuring:
Alexandra Chambers
‎Director, pan Canadian Oncology Drug Review (pCODR), CADTH

Understanding the Science of Biosimilars: How are they different from emerging drugs? What are they and how are they created?

Featuring:
Dr. Sandy Sehdev

Video 1: Introduction to Biosimilars

Video 4: Biosimilars in Clinical Practice Panel Discussion

Featuring:
Dr. Scott Berry
Dr. Sunil Verma
Dr. Sandy Sehdev

Video 3: Bevacizumab Biosimilars Clinical Considerations

Featuring:
Dr. Scott Berry

Video 2: Trastuzumab Biosimilars Clinical Considerations

Featuring:
Dr. Sunil Verma

Special Session - Biosimilars

Featuring:
Dr. Sunil Verma

From Bench to Bedside: Translating New Knowledge to Drug Development

Featuring:
Dr. Linh Nguyen

From Bedside to Bench – Understanding Immune-Therapy Resistance

Featuring:
Dr. Jason Luke

Biomarkers to Guide IO Therapy

Featuring:
Dr. Rosalyn Juergens

PD-L1 Testing in Routine Practice

Featuring:
Dr. Ming Tsao

Management of Immune-Therapy Related Adverse Events

Featuring:
Dr. David Hogg

Utilizing Immuno-Oncology Therapies in Clinical Practice

Featuring:
Dr. Michael Smylie

Beyond Checkpoint Inhibitors – Novel IO Therapies and IO-IO Combination Therapy

Featuring:
Dr. Jason Luke

IO Combination with Chemotherapy, Radiation and Targeted Therapies

Featuring:
Dr. Heather McArthur

Denosumab in Giant Cell Tumor of Bone

Featuring:
Dr. Emanuela Palmerini

Nivolumab & ISA 101 HPV vaccine in incurable HPV-16+ cancer

Featuring:
Dr. Erminia Massarelli

Antivascular Tumour Therapy

Featuring:
Dr. Urban Emmenegger

Molecular Targeting and Drug Design

Featuring:
Dr. Aaron Schimmer

Updates from Chicago 2017: Other Topics

June 3-7, 2017
Chicago, USA

Canadian Achievements in Cancer Research

Featuring:
Dr. Monika Kryzyzanowska

Canadian Achievements in Cancer Research

Featuring:
Sierra Cheng

Best of ASCO Montreal 2017 - Canadian Abstracts

Featuring:
Dr. Kim Ma

Health Sciences Research: Patient Reported Outcomes

Featuring:
Dr. Robert Olson

Debate - Medical Assistance in Dying

Featuring:
Dr. Charles Blanke
Dr. Howard Lim

Debate on Second Entry Biologic

Featuring:
PRO: Dr. Leigh Revers
CON: Dr. Sandy Sehdev

Promises and Challenges in Immuno-Oncology

Featuring:
Dr. Réjean Lapointe

Principles of Immuno-Oncology - A Clinician Perspective

Featuring:
Dr. Omid Hamid

MCBS in rare tumor entities

Featuring:
Dr. Barbara Kiesewetter

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors

Featuring:
Dr. Catharina Menke-van der Houven van Oordt

BAY 1163877

Featuring:
Dr. Markus Joerger

PRIME-NET study

Featuring:
Dr. Sara Pusceddu

Tumour gene expression data and clinical decision-making for patients with advanced cancers

Featuring:
Dr. Janessa Laskin

Trabectedin vs best supportive care in pretreated advanced soft tissue sarcoma

Featuring:
Dr. Axel Le Cesne

Lunch Symposium: Urothelial Cancers Management

Featuring:
Dr. Robert Dreicer

Round-Table Discussion on Pharmacoeconomics

Featuring:
Dr. Kathleen Barnard, Dr. Brent Fraser, Dr. Jaclyn Beca, Dr. Marcus Butler & Dr. Ilias Illiopolous
Chair: Dr. Sunil Verma

Keynote Presentation: Future Applications in Immuno-Oncology

Featuring:
Dr. Jason Luke

A New Way of Treating: Multidisciplinary Approach in Immuno-Therapy

Featuring:
Dr. David Hogg

Panel Discussion: Redefining Success in Oncology

Featuring:
Dr. Jason Luke, Kathleen Barnard, Christina Sit & Dr. Marcus Butler
Moderator: Dr. Rosalyn Juergens

Plenary Session Q&A

Featuring:
Dr. Jason Luke, Kathleen Barnard, Dr. Marcus Butler & Dr. Linh Nguyen
Chair: Dr. Sunil Verma

Immuno-Oncology: From Concept to Reality

Featuring:
Dr. Jason Luke

Beyond the Curve

Featuring:
Kathleen Barnard

Principles of Immuno-Oncology - An Immunologist Perspective

Featuring:
Dr. Linh Nguyen

Lorazepam as an Adjuvant to Haloperidol for Agitated Delirium at the End of Life

Featuring:
Dr. David Hui

CALM Trial

Featuring:
Dr. Gary Rodin

Psychological Intervention on the Fear of Cancer

Featuring:
Dr. Jane Beith

Korean Red Ginseng to Improve Cancer-Related Fatigue

Featuring:
Dr. Yeul Hong Kim

Immune response, safety, and survival impact in soft tissue sarcomas

Featuring:
Dr. Neeta Somaiah

Laboratory Methods in Translational Oncology Research

Featuring:
Dr. Kelsie Thu

Keynote Address: The Important Molecular/ Translational Endpoints In Clinical Trials

Featuring:
Dr. Kathy Pritchard

DNA Repair and Epigenetics

Featuring:
Dr. Rosalyn Juergens

Oncogenes/Tumour Suppressor Genes

Featuring:
Dr. Neesha Dhani

Signaling Pathways

Featuring:
Dr. Tony Mutsaers

Cell Cycle and Survival Mechanisms

Featuring:
Dr. David Cescon

Stem Cells

Featuring:
Dr. Catherine O'Brien

Tumour Immunobiology/ Immunotherapy

Featuring:
Dr. Marcus Butler

Invasion Metastasis

Featuring:
Dr. Richard Hill

Molecular Pathology

Featuring:
Dr. Ming Tsao

An Introduction to Biomarkers

Featuring:
Dr. Phil Bedard

Molecular Pharmacology/ Epidemiology

Featuring:
Dr. Geoff Liu

Canadian Achievements in Cancer Research

Featuring:
Dr. Kathy Pritchard

Best of ASCO Montreal 2016 - Neuroendocrine Cancers

Featuring:
Dr. Simron Singh

Highlights on Cancer and the Heart ASCO 2016

Featuring:
Dr. Susan Dent

Phase I study of sapacitabine and seliciclib

Featuring:
Dr. Sara Tolaney

Comorbidities & Risk of Peripheral Neuropathy in SWOG Trials

Featuring:
Dr. Dawn Hershman

Phase 1B Study of BGJ398 with BYL719

Featuring:
Dr. David Hyman

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy

Featuring:
Dr. Ian Kleckner

Precision Medicine in Cancer Care

Featuring:
Dr. Jonathan Trent

Panel Discussion: Cancer Care in 2025

Featuring:
Dr. Scott Berry

Perspective from BC Cancer Agency

Featuring:
Dr. Malcolm Moore

Perspective from Lung Cancer Canada

Featuring:
Dr. Paul Wheatley-Price

Perspective from Colorectal Cancer Association of Canada

Featuring:
Mr. Barry Stein

Perspective from CAMO

Featuring:
Dr. Christopher Lee

Perspective from CARO

Featuring:
Dr. Gerard Morton

Perspective from CSSO

Featuring:
Dr. Jay Engel

Perspective from Innovative Medicines Canada

Featuring:
Mr. Marc Zarenda

Webinar Archive: NETs Speaker Tour Montreal

Featuring:
Dr. Simron Singh

NETs Case Study

Featuring:
Dr. Petr Kavan

NETs in Québec

Featuring:
Dr. Albert Moghrabi

What's New with NETs?

Featuring:
Dr. Simron Singh

Best of Oncology West 2017 - Supportive Care

Featuring:
Dr. Corey Metcalf

Webinar Archive: NETs Speaker Tour Vancouver

Featuring:
Dr. Simron Singh
Dr. John Paul McGhie
Dr. Hagen Kennecke

NET Case Study

Featuring:
Dr. Hagen Kennecke

BC Perspective on NETs

Featuring:
Dr. John Paul McGhie

What's New With NETs?

Featuring:
Dr. Simron Singh

Webinar Archive: NETs Speaker Tour Toronto

Featuring:
Dr. Simron Singh
Dr. Calvin Law
Dr. Tim Asmis

Neuroendocrine Cancers: What's New With NETs?

Featuring:
Dr. Simron Singh

Advanced NETs

Featuring:
Dr. Calvin Law

Non-Functioning Small pNETS

Featuring:
Dr. Tim Asmis

Updates from Chicago 2017: Other Topics

June 3-7, 2017
Chicago, USA

Best of Oncology East 2018

November 30th, 2018
Toronto, ON

Canadian Immuno-Oncology Summit 2018

November 1st, 2018
Toronto, ON

Webinar Archive: NETs Speaker Tour Montreal

Featuring:
Dr. Simron Singh

Webinar Archive: NETs Speaker Tour Toronto

Featuring:
Dr. Simron Singh
Dr. Calvin Law
Dr. Tim Asmis

Webinar Archive: NETs Speaker Tour Vancouver

Featuring:
Dr. Simron Singh
Dr. John Paul McGhie
Dr. Hagen Kennecke

Perspective from BC Cancer Agency

Featuring:
Dr. Malcolm Moore

Oncogenes/Tumour Suppressor Genes

Featuring:
Dr. Neesha Dhani

Broad Indications for Immunotherapy

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

Routine ESAS use on OS

Featuring:
Dr. Lisa Barbera

FIGHT-202 Study

Featuring:
Dr. Arndt Vogel

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

Immune Related Complications From Immune Checkpoint Inhibitors - Pneumonitis

Featuring:
Dr. Shane Shapera

Lunch Presentation - Biosimilars in Oncology

Featuring:
Dr. Anil Abraham Joy
Dr. Sandeep Sehdev

Clinical Evidence For Immune-therapies In Practice - GI Cancers

Featuring:
Dr. Suneil Khanna

Clinical Evidence For Immune-therapies In Practice - Breast Cancers

Featuring:
Dr. Dave Cescon

Immune Related Complications From Immune Checkpoint Inhibitors - Nephritis

Featuring:
Dr. Gabrielle Cote

Clinical Evidence For Immune-therapies In Practice - GU Cancers

Featuring:
Dr. Nazanin Fallah-Rad

Monteluksat and Rupatadine and their combination with Rituximab

Featuring:
Dr. Rouslan Kotchetkov

Clinical Evidence For Immune-therapies In Practice - Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Immune Related Complications From Immune Checkpoint Inhibitors - Rhematologic

Featuring:
Dr. Raman Joshi

Immune Related Complications From Immune Checkpoint Inhibitors - Diarrhea/Colitis

Featuring:
Dr. Nazira Chatur

Principles of Immunotherapeutic Strategies

Featuring:
Dr. Linh Nguyen

Evidence For NTRK Inhibitors

Featuring:
Dr. David Hong & Dr. Adrian Sacher

Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte